Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amerisafe (AMSF) Cash & Equivalents (2016 - 2025)

Amerisafe's Cash & Equivalents history spans 16 years, with the latest figure at $61.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 40.6% year-over-year to $61.9 million; the TTM value through Dec 2025 reached $61.9 million, up 40.6%, while the annual FY2025 figure was $61.9 million, 40.6% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $61.9 million at Amerisafe, up from $54.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $123.1 million in Q3 2021 and bottomed at $30.6 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $51.6 million (2025), against an average of $55.4 million.
  • The largest annual shift saw Cash & Equivalents tumbled 60.24% in 2023 before it surged 58.33% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $70.7 million in 2021, then fell by 13.08% to $61.5 million in 2022, then plummeted by 37.07% to $38.7 million in 2023, then grew by 13.86% to $44.0 million in 2024, then skyrocketed by 40.6% to $61.9 million in 2025.
  • Per Business Quant, the three most recent readings for AMSF's Cash & Equivalents are $61.9 million (Q4 2025), $54.7 million (Q3 2025), and $48.5 million (Q2 2025).